Role of complement in multiorgan failure

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Rittirsch, Daniel ^a   Redl, Heinz ^b   Huber Lang, Markus ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b FEDERAL RESEARCH AND TRAINING CENTRE FOR FORESTS   (Austria)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BLOOD CLOTTING FACTOR 12A; CATECHOLAMINE; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT FACTOR D; CREATININE; FIBRIN; INTERCELLULAR ADHESION MOLECULE 1; LECTIN; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROPERDIN; PROTEIN KINASE B; SURFACTANT PROTEIN A; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD CLOTTING; CELL ADHESION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT SYSTEM; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRIN CLOT; FIBRINOLYSIS; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART PROTECTION; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY BLOOD FLOW; LIVER; LIVER CELL; LIVER FAILURE; MEDIATOR; MICROGLIA; MULTIPLE ORGAN FAILURE; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOSIS; TRAUMATIC BRAIN INJURY; URINE VOLUME; IMMUNOLOGY; INNATE IMMUNITY;

COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, INNATE; MULTIPLE ORGAN FAILURE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

MLCS; MLOWN;

EID: 84872131236     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/962927     Document Type: Review

References (131)

1. Baue A. E., Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Archives of Surgery 1975 110 7 779 781 2-s2.0-0016526956
2. Mayr V. D., Dünser M. W., Greil V., Jochberger S., Luckner G., Ulmer H., Friesenecker B. E., Takala J., Hasibeder W. R., Causes of death and determinants of outcome in critically ill patients. Critical Care 2006 10 6, article R154 2-s2.0-34247550890 10.1186/cc5086 (Pubitemid 47087015)
3. Blanco J., Muriel-Bombín A., Sagredo V., Taboada F., Gandía F., Tamayo L., Collado J., García-Labattut Á.., Carriedo D., Valledor M., De Frutos M., López M. J., Caballero A., Guerra J., Álvarez B., Mayo A., Villar J., Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Critical Care 2008 12 6, article R158 2-s2.0-58849147094 10.1186/cc7157
4. Martin G. S., Mannino D. M., Eaton S., Moss M., The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 2003 348 16 1546 1554 2-s2.0-0037451929 10.1056/NEJMoa022139 (Pubitemid 36437931)
5. Demetriades D., Murray J., Charalambides K., Alo K., Velmahos G., Rhee P., Chan L., Trauma fatalities: time and location of hospital deaths. Journal of the American College of Surgeons 2004 198 1 20 26 2-s2.0-1042299129 10.1016/j.jamcollsurg.2003.09.003 (Pubitemid 38201084)
6. Sauaia A., Moore F. A., Moore E. E., Moser K. S., Brennan R., Read R. A., Pons P. T., Epidemiology of trauma deaths: a reassessment. Journal of Trauma 1995 38 2 185 193 2-s2.0-0028909841
7. Baue A. E., MOF, MODS, and SIRS: what is in a name or an acronym? Shock 2006 26 5 438 449 2-s2.0-33750283880 10.1097/01.shk.0000228172.32587.7a (Pubitemid 44632272)
8. Marshall J. C., Cook D. J., Christou N. V., Bernard G. R., Sprung C. L., Sibbald W. J., Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Critical Care Medicine 1995 23 10 1638 1652 2-s2.0-0028784689 10.1097/00003246-199510000-00007
9. Vincent J. L., Moreno R., Takala J., Willatts S., De Mendonça A., Bruining H., Reinhart C. K., Suter P. M., Thijs L. G., The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine 1996 22 7 707 710 2-s2.0-0030015661 10.1007/s001340050156 (Pubitemid 26254283)
10. Durham R. M., Moran J. J., Mazuski J. E., Shapiro M. J., Baue A. E., Flint L. M., Multiple Organ Failure in Trauma Patients. Journal of Trauma 2003 55 4 608 616 2-s2.0-0142178297 10.1097/01.TA.0000092378.10660.D1 (Pubitemid 37322595)
11. Keel M., Trentz O., Pathophysiology of polytrauma. Injury 2005 36 6 691 709 2-s2.0-19544365744 10.1016/j.injury.2004.12.037 (Pubitemid 40732303)
12. Hotchkiss R. S., Karl I. E., The pathophysiology and treatment of sepsis. The New England Journal of Medicine 2003 348 2 138 150 2-s2.0-0037426726 10.1056/NEJMra021333 (Pubitemid 36056721)
13. Rittirsch D., Flierl M. A., Ward P. A., Harmful molecular mechanisms in sepsis. Nature Reviews Immunology 2008 8 10 776 787 2-s2.0-52949118458 10.1038/nri2402
14. Hotchkiss R. S., Swanson P. E., Freeman B. D., Tinsley K. W., Cobb J. P., Matuschak G. M., Buchman T. G., Karl I. E., Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Critical Care Medicine 1999 27 7 1230 1251 2-s2.0-0032770246 10.1097/00003246-199907000-00002 (Pubitemid 29379358)
15. Goya T., Morisaki T., Torisu M., Immunologic assessment of host defense impairment in patients with septic multiple organ failure: relationship between complement activation and changes in neutrophil function. Surgery 1994 115 2 145 155 2-s2.0-0028082347 (Pubitemid 24057482)
16. Hecke F., Schmidt U., Kola A., Bautsch W., Klos A., Köhl J., Circulating complement proteins in multiple trauma patients-correlation with injury severity, development of sepsis, and outcome. Critical Care Medicine 1997 25 12 2015 2024 2-s2.0-0031457117 10.1097/00003246-199712000-00019 (Pubitemid 28007240)
17. Fosse E., Pillgram-Larsen J., Svennevig J. L., Nordby C., Skulberg A., Mollnes T. E., Abdelnoor M., Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma. Injury 1998 29 7 509 514 2-s2.0-0032168542 10.1016/S0020-1383(98)00113-2 (Pubitemid 28423365)
18. Kang H. J., Kim J. H., Lee E. H., Lee Y. K., Hur M., Lee K. M., Change of complement system predicts the outcome of patients with severe thermal injury. Journal of Burn Care and Rehabilitation 2003 24 3 148 153 2-s2.0-0038247983 10.1097/01.BCR.0000066791.85810.BC (Pubitemid 36604423)
19. Bengtson A., Heideman M., Altered anaphylatoxin activity during induced hypoperfusion in acute and elective abdominal aortic surgery. Journal of Trauma 1986 26 7 631 637 2-s2.0-0022459082 (Pubitemid 16042916)
20. Nakae H., Endo S., Inada K., Yoshida M., Chronological changes in the complement system in sepsis. Surgery Today 1996 26 4 225 229 2-s2.0-0029912311 10.1007/BF00311579 (Pubitemid 26125848)
21. Ganter M. T., Brohi K., Cohen M. J., Shaffer L. A., Walsh M. C., Stahl G. L., Pittet J. F., Role of the alternative pathway in the early complement activation following major trauma. Shock 2007 28 1 29 34 2-s2.0-34250700510 10.1097/shk.0b013e3180342439 (Pubitemid 46956459)
22. Burk A. M., Martin M., Flierl M. A., Rittirsch D., Helm M., Early complementopathy after multiple injuries in humans. Shock 2012 37 348 354 10.1097/SHK.0b013e3182471795
23. Zimmermann T., Laszik Z., Nagy S., Kaszaki J., Joo F., The role of the complement system in the pathogenesis of multiple organ failure in shock. Progress in Clinical and Biological Research 1989 308 291 297 2-s2.0-0024407841
24. Huber-Lang M., Sarma V. J., Lu K. T., McGuire S. R., Padgaonkar V. A., Guo R. F., Younkin E. M., Kunkel R. G., Ding J., Erickson R., Curnutte J. T., Ward P. A., Role of C5a in multiorgan failure during sepsis. Journal of Immunology 2001 166 2 1193 1199 2-s2.0-0035863922 (Pubitemid 32060279)
25. Czermak B. J., Sarma V., Pierson C. L., Warner R. L., Huber-Lang M., Bless N. M., Schmal H., Friedl H. P., Ward P. A., Protective effects of C5a blockade in sepsis. Nature Medicine 1999 5 7 788 792 2-s2.0-0033052453 10.1038/10512 (Pubitemid 29318613)
26. Rittirsch D., Flierl M. A., Nadeau B. A., Day D. E., Huber-Lang M., Mackay C. R., Zetoune F. S., Gerard N. P., Cianflone K., Köhl J., Gerard C., Sarma J. V., Ward P. A., Functional roles for C5a receptors in sepsis. Nature Medicine 2008 14 5 551 557 2-s2.0-43249098418 10.1038/nm1753 (Pubitemid 351655216)
27. Laudes I. J., Chu J. C., Sikranth S., Huber-Lang M., Guo R. F., Riedemann N., Sarma J. V., Schmaier A. H., Ward P. A., Anti-C5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. American Journal of Pathology 2002 160 5 1867 1875 2-s2.0-0036092494 (Pubitemid 34525666)
28. Huber-Lang M., Sarma J. V., Zetoune F. S., Rittirsch D., Neff T. A., McGuire S. R., Lambris J. D., Warner R. L., Flierl M. A., Hoesel L. M., Gebhard F., Younger J. G., Drouin S. M., Wetsel R. A., Ward P. A., Generation of C5a in the absence of C3: a new complement activation pathway. Nature Medicine 2006 12 6 682 687 2-s2.0-33744987414 10.1038/nm1419 (Pubitemid 43865238)
29. Markiewski M. M., Nilsson B., Ekdahl K. N., Mollnes T. E., Lambris J. D., Complement and coagulation: strangers or partners in crime? Trends in Immunology 2007 28 4 184 192 2-s2.0-33947602404 10.1016/j.it.2007.02.006 (Pubitemid 46476881)
30. Amara U., Rittirsch D., Flierl M., Bruckner U., Klos A., Gebhard F., Lambris J. D., Huber-Lang M., Interaction between the coagulation and complement system. Advances in Experimental Medicine and Biology 2008 632 71 79 2-s2.0-58149349888
31. Reid K. B., Porter R. R., The proteolytic activation systems of complement. Annual Review of Biochemistry 1981 50 433 464 2-s2.0-0019364862
32. Muller-Eberhard H. J., Molecular organization and function of the complement system. Annual Review of Biochemistry 1988 57 321 347 2-s2.0-0023890664
33. Fujita T., Evolution of the lectin-complement pathway and its role in innate immunity. Nature Reviews Immunology 2002 2 5 346 353 2-s2.0-0036584407 (Pubitemid 37328757)
34. Amara U., Flierl M. A., Rittirsch D., Klos A., Chen H., Acker B., Brückner U. B., Nilsson B., Gebhard F., Lambris J. D., Huber-Lang M., Molecular intercommunication between the complement and coagulation systems. Journal of Immunology 2010 185 9 5628 5636 2-s2.0-78149477844 10.4049/jimmunol.0903678
35. Huber-Lang M., Younkin E. M., Sarma J. V., Riedemann N., McGuire S. R., Lu K. T., Kunkel R., Younger J. G., Zetoune F. S., Ward P. A., Generation of C5a by phagocytic cells. American Journal of Pathology 2002 161 5 1849 1859 2-s2.0-0036840236 (Pubitemid 35265542)
36. Vogt W., Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. Immunobiology 2000 201 3-4 470 477 2-s2.0-0033960683 (Pubitemid 30083848)
37. Sprung C. L., Schultz D. R., Marcial E., Complement activation in septic shock patients. Critical Care Medicine 1986 14 6 525 528 2-s2.0-0022477320 (Pubitemid 16085528)
38. Charchaflieh J., Wei J., Labaze G., Hou Y. J., Babarsh B., The role of complement system in septic shock. Clinical and Developmental Immunology 2012 2012 8 407324 10.1155/2012/407324
39. Bilgin Y. M., Brand A., Berger S. P., Daha M. R., Roos A., Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion 2008 48 4 601 608 2-s2.0-41149083693 10.1111/j.1537-2995.2007.01585.x (Pubitemid 351430334)
40. Eisen D. P., Dean M. M., Thomas P., Marshall P., Gerns N., Heatley S., Quinn J., Minchinton R. M., Lipman J., Low mannose-binding lectin function is associated with sepsis in adult patients. FEMS Immunology and Medical Microbiology 2006 48 2 274 282 2-s2.0-33750084149 10.1111/j.1574-695X.2006. 00144.x (Pubitemid 44581592)
41. Morgan B. P., Gasque P., Expression of complement in the brain: role in health and disease. Immunology Today 1996 17 10 461 466 2-s2.0-0030271257 10.1016/0167-5699(96)20028-F (Pubitemid 26323314)
42. Levi-Strauss M., Mallat M., Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. Journal of Immunology 1987 139 7 2361 2366 2-s2.0-0023226359 (Pubitemid 17152135)
43. Hosokawa M., Klegeris A., Maguire J., McGeer P. L., Expression of complement messenger RNAs and proteins by human oligodendroglial cells. GLIA 2003 42 4 417 423 2-s2.0-0038458963 10.1002/glia.10234 (Pubitemid 36702282)
44. Schmidt O. I., Heyde C. E., Ertel W., Stahel P. F., Closed head injury-an inflammatory disease? Brain Research Reviews 2005 48 2 388 399 2-s2.0-17844383934 10.1016/j.brainresrev.2004.12.028 (Pubitemid 40585769)
45. Flierl M. A., Rittirsch D., Huber-Lang M. S., Stahel P. F., Pathophysiology of septic encephalopathy-an unsolved puzzle. Critical Care 2010 14 3, article 165 2-s2.0-79952111807 10.1186/cc9035
46. Lindsberg P. J., Öhman J., Lehto T., Karjalainen-Lindsberg M. L., Paetau A., Wuorimaa T., Carpén O., Kaste M., Meri S., Complement activation in the central nervous system following blood- brain barrier damage in man. Annals of Neurology 1996 40 4 587 596 2-s2.0-0029910943 10.1002/ana.410400408 (Pubitemid 26357883)
47. Stahel P. F., Morganti-Kossmann M. C., Kossmann T., The role of the complement system in traumatic brain injury. Brain Research Reviews 1998 27 3 243 256 2-s2.0-0031815054 10.1016/S0165-0173(98)00015-0 (Pubitemid 28389310)
48. Lynch N. J., Willis C. L., Nolan C. C., Roscher S., Fowler M. J., Weihe E., Ray D. E., Schwaeble W. J., Microglial activation and increased synthesis of complement component C1q precedes blood-brain barrier dysfunction in rats. Molecular Immunology 2004 40 10 709 716 2-s2.0-0344413470 10.1016/j.molimm.2003. 08.009 (Pubitemid 37487946)
49. Weiss S. J., Tissue destruction by neutrophils. The New England Journal of Medicine 1989 320 6 365 376 2-s2.0-0024602827 (Pubitemid 19106873)
50. Flierl M. A., Stahel P. F., Rittirsch D., Huber-Lang M., Niederbichler A. D., Marco L. M., Touban B. M., Morgan S. J., Smith W. R., Ward P. A., Ipaktchi K., Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis. Critical Care 2009 13 1, article R12 2-s2.0-61649087203 10.1186/cc7710
51. Keeling K. L., Hicks R. R., Mahesh J., Billings B. B., Kotwal G. J., Local neutrophil influx following lateral fluid-percussion brain injury in rats is associated with accumulation of complement activation fragments of the third component (C3) of the complement system. Journal of Neuroimmunology 2000 105 1 20 30 2-s2.0-0034212894 10.1016/S0165-5728(00)00183-1 (Pubitemid 30125425)
52. Leinhase I., Holers V. M., Thurman J. M., Harhausen D., Schmidt O. I., Pietzcker M., Taha M. E., Rittirsch D., Huber-Lang M., Smith W. R., Ward P. A., Stahel P. F., Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neuroscience 2006 7, article no. 55 2-s2.0-33847147536 10.1186/1471-2202-7-55 (Pubitemid 46277111)
53. Leinhase I., Rozanski M., Harhausen D., Thurman J. M., Schmidt O. I., Hossini A. M., Taha M. E., Rittirsch D., Ward P. A., Holersl V. M., Ertel W., Stahel P. F., Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice. Journal of Neuroinflammation 2007 4, article 13 2-s2.0-34248676285 10.1186/1742-2094-4-13 (Pubitemid 46767754)
54. Farkas I., Baranyi L., Takahashi M., Fukuda A., Liposits Z., Yamamoto T., Okada H., A neuronal C5a receptor and an associated apoptotic signal transduction pathway. Journal of Physiology 1998 507 3 679 687 2-s2.0-0032520865 10.1111/j.1469-7793.1998.679bs.x (Pubitemid 28143569)
55. Nataf S., Stahel P. F., Davoust N., Barnum S. R., Complement anaphylatoxin receptors on neurons: new tricks for old receptors? Trends in Neurosciences 1999 22 9 397 402 2-s2.0-0033198678 10.1016/S0166-2236(98)01390-3 (Pubitemid 29453644)
56. Singhrao S. K., Neal J. W., Rushmere N. K., Morgan B. P., Gasque P., Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis. American Journal of Pathology 2000 157 3 905 918 2-s2.0-0034495294 (Pubitemid 32109383)
57. Osaka H., Mukherjee P., Aisen P. S., Pasinetti G. M., Complement-derived anaphylatoxin C5a protects against glutamate-mediated neurotoxicity. Journal of Cellular Biochemistry 1999 73 303 311 (Pubitemid 29198005)
58. Heese K., Hock C., Otten U., Inflammatory signals induce neurotrophin expression in human microglial cells. Journal of Neurochemistry 1998 70 2 699 707 2-s2.0-0031913982 (Pubitemid 28079359)
59. Clark C. J., Reid W. H., Pollock A. J., Campbell D., Gemmell C., Role of pulmonary alveolar macrophage activation in acute lung injury after burns and smoke inhalation. The Lancet 1988 2 8616 872 874 2-s2.0-0023731328
60. White T. O., Jenkins P. J., Smith R. D., Cartlidge C. W. J., Robinson C. M., The epidemiology of posttraumatic adult respiratory distress syndrome. Journal of Bone and Joint Surgery A 2004 86 11 2366 2376 2-s2.0-8144219863 (Pubitemid 39473074)
61. Rubenfeld G. D., Caldwell E., Peabody E., Weaver J., Martin D. P., Neff M., Stern E. J., Hudson L. D., Incidence and outcomes of acute lung injury. The New England Journal of Medicine 2005 353 16 1685 1693 2-s2.0-26844552488 10.1056/NEJMoa050333 (Pubitemid 41464707)
62. Hetland G., Johnson E., Aasebo U., Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro. Scandinavian Journal of Immunology 1986 24 5 603 608 2-s2.0-0022976676 (Pubitemid 17189281)
63. Strunk R. C., Eidlen D. M., Mason R. J., Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. Journal of Clinical Investigation 1988 81 5 1419 1426 2-s2.0-0023893101
64. Rothman B. L., Merrow M., Despins A., Kennedy T., Kreutzer D. L., Effect of lipopolysaccharide on C3 and C5 production by human lung cells. Journal of Immunology 1989 143 1 196 202 2-s2.0-0024317713 (Pubitemid 19174220)
65. Watford W. T., Ghio A. J., Wright J. R., Complement-mediated host defense in the lung. American Journal of Physiology 2000 279 5 L790 L798 2-s2.0-0033682057
66. Watford W. T., Wright J. R., Hester C. G., Jiang H., Frank M. M., Surfactant protein A regulates complement activation. Journal of Immunology 2001 167 11 6593 6600 2-s2.0-0035576395 (Pubitemid 33081596)
67. Hammerschmidt D. E., Weaver L. J., Hudson L. D., Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Pathophysiological relevance and possible prognostic value. The Lancet 1980 1 8175 947 949 2-s2.0-0018857939 (Pubitemid 10150800)
68. Solomkin J. S., Cotta L. A., Satoh P. S., Hurst J. M., Nelson R. D., Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man. Surgery 1985 97 6 668 678 2-s2.0-0022333364 (Pubitemid 16163132)
69. Langlois P. F., Gawryl M. S., Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. American Review of Respiratory Disease 1988 138 2 368 375 2-s2.0-0023769732
70. Zilow G., Sturm J. A., Rother U., Kirschfink M., Complement activation and the prognostic value of C3a in patients at risk of adult respiratory distress syndrome. Clinical and Experimental Immunology 1990 79 2 151 157 2-s2.0-0025122303 (Pubitemid 20058448)
71. Weinberg P. F., Matthay M. A., Webster R. O., Roskos K. V., Goldstein I. M., Murray J. F., Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. American Review of Respiratory Disease 1984 130 5 791 796 2-s2.0-0021702169 (Pubitemid 15209562)
72. Bosmann M., Ward P. A., Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis. Advances in Experimental Medicine and Biology 2012 946 147 159
73. Guo R. F., Ward P. A., Role of C5a in inflammatory responses. Annual Review of Immunology 2005 23 821 852 2-s2.0-17644388462 10.1146/annurev.immunol. 23.021704.115835 (Pubitemid 40563186)
74. Seeger W., Gunther A., Walmrath H. D., Grimminger F., Lasch H. G., Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clinical Investigator 1993 71 3 177 190 2-s2.0-0027468043 (Pubitemid 23077027)
75. Carvalho A. C., DeMarinis S., Scott C. F., Silver L. D., Schmaier A. H., Colman R. W., Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome. Journal of Laboratory and Clinical Medicine 1988 112 2 270 277 2-s2.0-0023677332
76. Fuchs-Buder T., De Moerloose P., Ricou B., Reber G., Vifian C., Nicod L., Romand J. A., Suter P. M., Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 1996 153 1 163 167 2-s2.0-0030053131 (Pubitemid 26026844)
77. Seeger W., Hubel J., Klapettek K., Pison U., Obertacke U., Joka T., Roka L., Procoagulant activity in bronchoalveolar lavage of severely traumatized patients-relation to the development of acute respiratory distress. Thrombosis Research 1991 61 1 53 64 2-s2.0-0025961376 10.1016/0049-3848(91)90168-V
78. Balk R., Emerson T., Fourrier F., Kruse J. A., Mammen E. F., Schuster H. P., Vinazzer H., Therapeutic use of antithrombin concentrate in sepsis. Seminars in Thrombosis and Hemostasis 1998 24 2 183 194 2-s2.0-0031894499 (Pubitemid 28180830)
79. Abraham E., Coagulation abnormalities in acute lung injury and sepsis. American Journal of Respiratory Cell and Molecular Biology 2000 22 4 401 404 2-s2.0-0034094887 (Pubitemid 30343338)
80. Krishnagopalan S., Kumar A., Parrillo J. E., Kumar A., Myocardial dysfunction in the patient with sepsis. Current Opinion in Critical Care 2002 8 5 376 388 2-s2.0-0036791175 10.1097/00075198-200210000-00003
81. Kumar A., Brar R., Wang P., Dee L., Skorupa G., Khadour F., Schulz R., Parrillo J. E., Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. American Journal of Physiology 1999 276 1 R265 R276 2-s2.0-0032891779 (Pubitemid 29061717)
82. Burke J. A., Levi R., Guo Z. G., Corey E. J., Leukotrienes C4, D4 and E4: effects on human and guinea-pig cardiac preparations in vitro. Journal of Pharmacology and Experimental Therapeutics 1982 221 1 235 241 2-s2.0-0020003783 (Pubitemid 12156497)
83. Carli A., Auclair M. C., Vernimmen C., Indomethacin suppresses the early cardiodepressant factor released by endotoxin in the rat: possible involvement of a prostacyclin-related material. Advances in Shock Research 1983 10 161 171 2-s2.0-0020656347
84. Goldfarb R. D., Weber P., Eisenman J., Isolation of a shock-induced circulating cardiodepressant substance. The American Journal of Physiology 1979 237 2 H168 H177 2-s2.0-0018509033
85. Odeh M., Tumor necrosis factor- α as a myocardial depressant substance. International Journal of Cardiology 1993 42 3 231 238 2-s2.0-0027787457 10.1016/0167-5273(93)90053-J
86. Parrillo J. E., Burch C., Shelhamer J. H., Parker M. M., Natanson C., Schuette W., A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. Journal of Clinical Investigation 1985 76 4 1539 1553 2-s2.0-0022409016 (Pubitemid 16193573)
87. Moran K. T., O'Reilly T. J., Allo M., Munster A. M., Anaphylotoxin levels following thermal injury. Burns 1987 13 4 266 268 2-s2.0-0023391411
88. Schirmer W. J., Schirmer J. M., Naff G. B., Fry D. E., Systemic complement activation produces hemodynamic changes characteristic of sepsis. Archives of Surgery 1988 123 3 316 321 2-s2.0-0023937859 (Pubitemid 18093300)
89. Schirmer W. J., Schirmer J. M., Naff G. B., Fry D. E., Complement-mediated hemodynamic depression in the early postburn period. Journal of Trauma 1989 29 7 932 939 2-s2.0-0024400622 (Pubitemid 19211383)
90. Niederbichler A. D., Hoesel L. M., Westfall M. V., Gao H., Ipaktchi K. R., Sun L., Zetoune F. S., Su G. L., Arbabi S., Sarma J. V., Wang S. C., Hemmila M. R., Ward P. A., An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction. Journal of Experimental Medicine 2006 203 1 53 61 2-s2.0-31344464342 10.1084/jem.20051207 (Pubitemid 43139645)
91. Hoesel L. M., Niederbichler A. D., Schaefer J., Ipaktchi K. R., Gao H., Rittirsch D., Pianko M. J., Vogt P. M., Sarma J. V., Su G. L., Arbabi S., Westfall M. V., Wang S. C., Hemmila M. R., Ward P. A., C5a-blockade improves burn-induced cardiac dysfunction. Journal of Immunology 2007 178 12 7902 7910 2-s2.0-34250218509 (Pubitemid 46898062)
92. Wu L. L., Ji Y., Dong L. W., Liu M. S., Calcium uptake by sarcoplasmic reticulum is impaired during the hypodynamic phase of sepsis in the rat heart. Shock 2001 15 1 49 55 2-s2.0-0035234205 (Pubitemid 33598160)
93. Watts J. A., Kline J. A., Thornton L. R., Grattan R. M., Brar S. S., Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. Journal of Molecular and Cellular Cardiology 2004 36 1 141 150 2-s2.0-0345743533 10.1016/j.yjmcc.2003.10.015 (Pubitemid 38084799)
94. Atefi G., Zetoune F. S., Herron T. J., Jalife J., Bosmann M., Al-Aref R., Sarma J. V., Ward P. A., Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB Journal 2011 25 7 2500 2508 2-s2.0-79960196840 10.1096/fj.11-183236
95. Levy R. J., Piel D. A., Acton P. D., Zhou R., Ferrari V. A., Karp J. S., Deutschman C. S., Evidence of myocardial hibernation in the septic heart. Critical Care Medicine 2005 33 12 2752 2756 2-s2.0-29144530137 10.1097/01.CCM.0000189943.60945.77 (Pubitemid 41816407)
96. Chakraborti T., Mandal A., Mandal M., Das S., Chakraborti S., Complement activation in heart diseases: role of oxidants. Cellular Signalling 2000 12 9-10 607 617 2-s2.0-0033741888 10.1016/S0898-6568(00)00111-X
97. Murohara T., Guo J., Delyani J. A., Lefer A. M., Cardioprotective effects of selective inhibition of the two complement activation pathways in myocardial ischemia and reperfusion injury. Methods and Findings in Experimental and Clinical Pharmacology 1995 17 8 499 507 2-s2.0-0028884415
98. Buerke M., Prüfer D., Dahm M., Oelert H., Meyer J., Darius H., Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. Journal of Pharmacology and Experimental Therapeutics 1998 286 1 429 438 2-s2.0-0031849695 (Pubitemid 28318019)
99. Fu J., Lin G., Zeng B., Wu Z., Wu Y., Chu H., Qin G., Liang G., Li J., Gan X., Yu X., Li C., Liu D., Anti-ischemia/reperfusion of C1 inhibitor in myocardial cell injury via regulation of local myocardial C3 activity. Biochemical and Biophysical Research Communications 2006 350 1 162 168 2-s2.0-33749063415 10.1016/j.bbrc.2006.09.023 (Pubitemid 44466587)
100. Fu J., Lin G., Wu Z., Ceng B., Wu Y., Liang G., Qin G., Li J., Chiu I., Liu D., Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury. Biochemical and Biophysical Research Communications 2006 349 2 504 512 2-s2.0-33748439358 10.1016/j.bbrc.2006.08.065 (Pubitemid 44344551)
101. Whaley K., Schwaeble W., Complement and complement deficiencies. Seminars in Liver Disease 1997 17 4 297 310 2-s2.0-0030679662 (Pubitemid 27527654)
102. Koo D. J., Chaudry I. H., Wang P., Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis. Journal of Surgical Research 1999 83 2 151 157 2-s2.0-0033562174 10.1006/jsre.1999.5584 (Pubitemid 29391622)
103. Sheth K., Bankey P., The liver as an immune organ. Current Opinion in Critical Care 2001 7 2 99 104 2-s2.0-0035022608 10.1097/00075198-200104000-00008 (Pubitemid 32411398)
104. Croner R. S., Lehmann T. G., Fallsehr C., Herfarth C., Klar E., Kirschfink M., C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat. Microvascular Research 2004 67 2 182 191 2-s2.0-1542358725 10.1016/j.mvr.2003.09.009 (Pubitemid 38327004)
105. Jaeschke H., Cellular adhesion molecules: regulation and functional significance in the pathogenesis of liver diseases. American Journal of Physiology 1997 273 3 G602 G611 2-s2.0-0030760637 (Pubitemid 27418779)
106. Jaeschke H., Farhood A., Fisher M. A., Smith C. W., Sequestration of neutrophils in the hepatic vasculature during endotoxemia is independent of β 2 integrins and intercellular adhesion molecule-1. Shock 1996 6 5 351 356 2-s2.0-0030278393 (Pubitemid 126727114)
107. Koch C. A., Kanazawa A., Nishitai R., Knudsen B. E., Ogata K., Plummer T. B., Butters K., Platt J. L., Intrinsic resistance of hepatocytes to complement-mediated injury. Journal of Immunology 2005 174 11 7302 7309 2-s2.0-18944401943 (Pubitemid 40705700)
108. Jacob A. I., Goldberg P. K., Bloom N., Endotoxin and bacteria in portal blood. Gastroenterology 1977 72 6 1268 1270 2-s2.0-0017685906 (Pubitemid 8116697)
109. Wrann C. D., Tabriz N. A., Barkhausen T., Klos A., Van Griensven M., Pape H. C., Kendoff D. O., Guo R., Ward P. A., Krettek C., Riedemann N. C., The phosphatidylinositol 3-kinase signaling pathway exerts protective effects during sepsis by controlling C5a-mediated activation of innate immune functions. Journal of Immunology 2007 178 9 5940 5948 2-s2.0-34247643153 (Pubitemid 46674391)
110. Cunningham P. N., Holers V. M., Alexander J. J., Guthridge J. M., Carroll M. C., Quigg R. J., Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. Kidney International 2000 58 4 1580 1587 2-s2.0-0033801895 10.1046/j.1523-1755.2000.00319.x
111. Camussi G., Ronco C., Montrucchio G., Piccoli G., Role of soluble mediators in sepsis and renal failure. Kidney International 1998 53 66 S38 S42 2-s2.0-0031948489
112. Oppermann M., Haubitz M., Quentin E., Gotze O., Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B. Klinische Wochenschrift 1988 66 18 857 864 2-s2.0-0023759672
113. Ault B. H., Colten H. R., Cellular specificity of murine renal C3 expression in two models of inflammation. Immunology 1994 81 4 655 660 2-s2.0-0028094853 (Pubitemid 24246519)
114. Brooimans R. A., Stegmann A. P. A., Van Dorp W. T., Van der Ark A. A. J., Van der Woude F. J., Van Es L. A., Daha M. R., Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. Journal of Clinical Investigation 1991 88 2 379 384 2-s2.0-0025879226
115. Tang S., Zhou W., Sheerin N. S., Vaughan R. W., Sacks S. H., Contribution of renal secreted complement C3 to the circulating pool in humans. Journal of Immunology 1999 162 7 4336 4341 2-s2.0-0033120556 (Pubitemid 29314826)
116. Biancone L., David S., Pietra V. D., Montrucchio G., Cambi V., Camussi G., Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney International 1994 45 2 451 460 2-s2.0-0028055096 (Pubitemid 24065080)
117. Ichida S., Yuzawa Y., Okada H., Yoshioka K., Matsuo S., Localization of the complement regulatory proteins in the normal human kidney. Kidney International 1994 46 1 89 96 2-s2.0-0028239796 (Pubitemid 24210439)
118. Thurman J. M., Lucia M. S., Ljubanovic D., Holers V. M., Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney International 2005 67 2 524 530 2-s2.0-12344333421 10.1111/j.1523-1755.2005.67109.x (Pubitemid 40139844)
119. Smedegard G., Cui L., Hugli T. E., Endotoxin-induced shock in the rat. A role for C5a. American Journal of Pathology 1989 135 3 489 497 2-s2.0-0024450510 (Pubitemid 19246207)
120. Krem M. M., Cera E. D., Evolution of enzyme cascades from embryonic development to blood coagulation. Trends in Biochemical Sciences 2002 27 2 67 74 2-s2.0-0036470428 10.1016/S0968-0004(01)02007-2 (Pubitemid 34164321)
121. Esmon C. T., The impact of the inflammatory response on coagulation. Thrombosis Research 2004 114 5-6 321 327 2-s2.0-7044262108 10.1016/j.thromres. 2004.06.028 (Pubitemid 39422563)
122. Gando S., Kameue T., Matsuda N., Hayakawa M., Ishitani T., Morimoto Y., Kemmotsu O., Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thrombosis and Haemostasis 2002 88 6 943 949 2-s2.0-0036912250 (Pubitemid 36018780)
123. Levi M., De Jonge E., Van Der Poll T., New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology. Annals of Medicine 2004 36 1 41 49 2-s2.0-1242337462 10.1080/07853890310017251 (Pubitemid 38230698)
124. Ghebrehiwet B., Silverberg M., Kaplan A. P., Activation of the classical pathway of complement by Hageman factor fragment. Journal of Experimental Medicine 1981 153 3 665 676 2-s2.0-0019471542 (Pubitemid 11155801)
125. Goldberger G., Thomas M. L., Tack B. F., NH2-terminal structure and cleavage of guinea pig pro-C3, the precursor of the third complement component. Journal of Biological Chemistry 1981 256 24 12617 12619 2-s2.0-0019731231 (Pubitemid 12132894)
126. Thoman M. L., Meuth J. L., Morgan E. L., C3d-K, a kallikrein cleavage fragment of iC3b is a potent inhibitor of cellular proliferation. Journal of Immunology 1984 133 5 2629 2633 2-s2.0-0021746103 (Pubitemid 15204796)
127. Muhlfelder T. W., Niemetz J., Kreutzer D., C5 chemotactic fragment induces leukocyte production of tissue factor activity. A link between complement and coagulation. Journal of Clinical Investigation 1979 63 1 147 150 2-s2.0-0018411524 (Pubitemid 9085091)
128. Rezende S. M., Simmonds R. E., Lane D. A., Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex. Blood 2004 103 4 1192 1201 2-s2.0-0842328856 10.1182/blood-2003-05-1551 (Pubitemid 38168627)
129. Bernard G. R., Vincent J. L., Laterre P. F., LaRosa S. P., Dhainaut J. F., Lopez-Rodriguez A., Steingrub J. S., Garber G. E., Helterbrand J. D., Ely E. W., Fisher C. J., Efficacy and safety of recombinant human activated protein C for severe sepsis. The New England Journal of Medicine 2001 344 10 699 709 2-s2.0-0035826096 10.1056/NEJM200103083441001 (Pubitemid 32204987)
130. Caliezi C., Zeerleder S., Redondo M., Regli B., Rothen H. U., Zürcher-Zenklusen R., Rieben R., Devay J., Hack C. E., Lämmle B., Wuillemin W. A., C1-inhibitor in patients with severe sepsis and septic shock: beneficial effect on renal dysfunction. Critical Care Medicine 2002 30 8 1722 1728 2-s2.0-0036348546 (Pubitemid 34879581)
131. Silasi-Mansat R., Zhu H., Popescu N. I., Peer G., Sfyroera G., Magotti P., Ivanciu L., Lupu C., Mollnes T. E., Taylor F. B., Kinasewitz G., Lambris J. D., Lupu F., Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood 2010 116 6 1002 1010 2-s2.0-77955901581 10.1182/blood-2010-02-269746